John T Cavan Hepion Pharmaceuticals, Inc. (HEPA) insider trading activity

HEPA Quotes by TradingView

John T Cavan is Chief Financial Officer of Hepion Pharmaceuticals, Inc.. Currently has a direct ownership of 14,800 shares of HEPA, which is worth approximately $10,952. The most recent transaction as insider was on Feb 18, 2021, when has been sold 10,000 shares (Common Stock) at a price of $2.0 per share, resulting in proceeds of $20,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.8K
0% 3M change
0% 12M change
Total Value Held $10,952

John T Cavan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 18 2021
BUY
Open market or private purchase
$20,000 $2.0 p/Share
10,000 Added 40.32%
14,800 Common Stock
Nov 25 2020
BUY
Open market or private purchase
$7,290 $1.62 p/Share
4,500 Added 48.39%
4,800 Common Stock
JTC

John T Cavan

Chief Financial Officer
Edison, NJ

Track Institutional and Insider Activities on HEPA

Follow Hepion Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HEPA shares.

Notify only if

Insider Trading

Get notified when an Hepion Pharmaceuticals, Inc. insider buys or sells HEPA shares.

Notify only if

News

Receive news related to Hepion Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on HEPA